{"id":2398,"date":"2021-07-12T06:00:00","date_gmt":"2021-07-12T06:00:00","guid":{"rendered":"https:\/\/www.govisachina.com\/?p=2398"},"modified":"2021-07-12T09:32:25","modified_gmt":"2021-07-12T09:32:25","slug":"chinas-coronavac-vaccine-gives-over-90-percent-protection-from-icu-admission-in-chile-study","status":"publish","type":"post","link":"https:\/\/www.govisachina.com\/zh\/2021\/07\/12\/chinas-coronavac-vaccine-gives-over-90-percent-protection-from-icu-admission-in-chile-study\/","title":{"rendered":"China&#8217;s CoronaVac vaccine gives over 90-percent protection from ICU admission in Chile: study"},"content":{"rendered":"<p class=\"wp-block-paragraph\">SANTIAGO, July 10 (Xinhua) &#8212; China&#8217;s CoronaVac COVID-19 vaccine effectively prevented COVID-19 in Chile, with the adjusted vaccine effectiveness reaching 90.3 percent for the prevention of severe disease, according to a study recently published in the New England Journal of Medicine.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">A nationwide mass vaccination campaign was conducted from Feb. 2 to May 1, and a cohort including approximately 10.2 million people aged 16 years and above was used, according to the study titled Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile published on Wednesday.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Among those who were fully immunized, the adjusted vaccine effectiveness was 65.9 percent for the prevention of COVID-19, 87.5 percent for the prevention of hospitalization, and 86.3 percent for the prevention of COVID-19-related death, the results of the study showed.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The CoronaVac, also known as the Sinovac COVID-19 vaccine, is an inactivated virus COVID-19 vaccine developed by Chinese pharmaceutical company Sinovac Biotech.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">CoronaVac uses an inactivated whole virus, compelling a recipient&#8217;s immune system to attack the harmless form of the virus by producing antibodies to fight it off, thus leading to immunity. <\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Source: http:\/\/www.xinhuanet.com\/english\/2021-07\/10\/c_1310053763.htm <\/p>","protected":false},"excerpt":{"rendered":"<p>SANTIAGO, July 10 (Xinhua) &#8212; China&#8217;s CoronaVac COVID-19 vaccine effectively prevented COVID-19 in Chile, with the adjusted vaccine effectiveness reaching 90.3 percent for the prevention of severe disease, according to a study recently published in the New England Journal of Medicine. A nationwide mass vaccination campaign was conducted from Feb. [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_themeisle_gutenberg_block_has_review":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[28],"tags":[],"class_list":["post-2398","post","type-post","status-publish","format-standard","hentry","category-covid-19"],"jetpack_publicize_connections":[],"jetpack_sharing_enabled":true,"jetpack-related-posts":[{"id":2314,"url":"https:\/\/www.govisachina.com\/zh\/2021\/06\/02\/who-validates-chinas-sinovac-covid-19-vaccine-for-emergency-use\/","url_meta":{"origin":2398,"position":0},"title":"WHO validates China&#8217;s Sinovac COVID-19 vaccine for emergency use","author":"Visa China","date":"2 6 \u6708, 2021","format":false,"excerpt":"GENEVA, June 1 (Xinhua) The World Health Organization (WHO) validated on Tuesday the CoronaVac COVID-19 vaccine developed by Chinese pharmaceutical company Sinovac for emergency use. \"I am happy to announce that the Sinovac coronavirus vaccine has been given WHO Emergency Use Listing (EUL) after being found to be safe, effective,\u2026","rel":"","context":"\u5728\u201cCOVID-19\u201d\u4e2d","block_context":{"text":"COVID-19","link":"https:\/\/www.govisachina.com\/zh\/category\/covid-19\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.govisachina.com\/wp-content\/uploads\/2021\/06\/vaccine-5895477_1920.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.govisachina.com\/wp-content\/uploads\/2021\/06\/vaccine-5895477_1920.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.govisachina.com\/wp-content\/uploads\/2021\/06\/vaccine-5895477_1920.jpg?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.govisachina.com\/wp-content\/uploads\/2021\/06\/vaccine-5895477_1920.jpg?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/www.govisachina.com\/wp-content\/uploads\/2021\/06\/vaccine-5895477_1920.jpg?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/www.govisachina.com\/wp-content\/uploads\/2021\/06\/vaccine-5895477_1920.jpg?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":2401,"url":"https:\/\/www.govisachina.com\/zh\/2021\/07\/13\/providing-500-mln-vaccine-doses-to-world-china-aims-to-enhance-intl-cooperation-against-covid-19\/","url_meta":{"origin":2398,"position":1},"title":"Providing 500 mln vaccine doses to world, China aims to enhance int&#8217;l cooperation against COVID-19","author":"Visa China","date":"13 7 \u6708, 2021","format":false,"excerpt":"BEIJING, July 13 (Xinhua) -- Chinese vaccines are gathering steam across the world, injecting strong impetus into the global fight against COVID-19 as deaths from the virus topped 4 million worldwide and variants spread to more than 100 countries. As a steadfast advocate for equitable vaccine distribution around the globe,\u2026","rel":"","context":"\u5728\u201cCOVID-19\u201d\u4e2d","block_context":{"text":"COVID-19","link":"https:\/\/www.govisachina.com\/zh\/category\/covid-19\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":2467,"url":"https:\/\/www.govisachina.com\/zh\/2021\/08\/20\/malaysia-takes-first-delivery-of-chinas-cansino-covid-19-vaccine\/","url_meta":{"origin":2398,"position":2},"title":"Malaysia takes first delivery of China&#8217;s CanSino COVID-19 vaccine","author":"Visa China","date":"20 8 \u6708, 2021","format":false,"excerpt":"KUALA LUMPUR, Aug. 20 (Xinhua) -- The first batch of the single-dose COVID-19 vaccine developed by Chinese company CanSino Biologics arrived in Malaysia on Friday, boosting the country's capability in the fight against the pandemic. The first batch, comprising some 200,000 finished products, is part of a total of 3.5\u2026","rel":"","context":"\u5728\u201cCOVID-19\u201d\u4e2d","block_context":{"text":"COVID-19","link":"https:\/\/www.govisachina.com\/zh\/category\/covid-19\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":2421,"url":"https:\/\/www.govisachina.com\/zh\/2021\/07\/30\/roundup-chinese-covid-19-vaccines-effective-against-infection-mortality\/","url_meta":{"origin":2398,"position":3},"title":"Roundup: Chinese COVID-19 vaccines effective against infection, mortality","author":"Visa China","date":"30 7 \u6708, 2021","format":false,"excerpt":"BUENOS AIRES, July 30 (Xinhua) -- Experts in viral diseases and infectology have highlighted the efficacy of Chinese vaccines against COVID-19 and its new variants. \"According to the evidence available so far, vaccines that have been licensed by the World Health Organization (WHO) are effective against all variants in circulation\u2026","rel":"","context":"\u7c7b\u4f3c\u6587\u7ae0","block_context":{"text":"\u7c7b\u4f3c\u6587\u7ae0","link":""},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":2202,"url":"https:\/\/www.govisachina.com\/zh\/2021\/05\/17\/chinas-sinopharm-covid-19-vaccine-likely-conducive-to-global-vaccine-accessibility-indian-newspaper\/","url_meta":{"origin":2398,"position":4},"title":"China&#8217;s Sinopharm COVID-19 vaccine likely conducive to global vaccine accessibility: Indian newspaper","author":"Visa China","date":"17 5 \u6708, 2021","format":false,"excerpt":"Xinhua\u00a0 NEW DELHI - China's Sinopharm COVID-19 vaccine, the first non-Western vaccine supported by the World Health Organization (WHO), is likely to be used in the COVAX program, which provides vaccines to low- and middle-income countries, reported the Indian Express newspaper Thursday. The WHO last week validated the China-developed vaccine\u2026","rel":"","context":"\u5728\u201cCOVID-19\u201d\u4e2d","block_context":{"text":"COVID-19","link":"https:\/\/www.govisachina.com\/zh\/category\/covid-19\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":2445,"url":"https:\/\/www.govisachina.com\/zh\/2021\/08\/11\/chinese-vaccine-makers-help-boost-supplies-overseas\/","url_meta":{"origin":2398,"position":5},"title":"Chinese vaccine makers help boost supplies overseas","author":"Visa China","date":"11 8 \u6708, 2021","format":false,"excerpt":"A staff member transports China's Sinovac COVID-19 vaccines at the Phnom Penh International Airport in Phnom Penh, Cambodia, July 31, 2021. (Photo\/Xinhua) Chinese vaccine makers are deepening cooperation with foreign countries to facilitate local production of their COVID-19 shots and promote technology transfers, as part of intensifying efforts to boost\u2026","rel":"","context":"\u5728\u201cCOVID-19\u201d\u4e2d","block_context":{"text":"COVID-19","link":"https:\/\/www.govisachina.com\/zh\/category\/covid-19\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.govisachina.com\/wp-content\/uploads\/2021\/08\/pic1-37972726.jpeg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.govisachina.com\/wp-content\/uploads\/2021\/08\/pic1-37972726.jpeg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.govisachina.com\/wp-content\/uploads\/2021\/08\/pic1-37972726.jpeg?resize=525%2C300&ssl=1 1.5x"},"classes":[]}],"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/www.govisachina.com\/zh\/wp-json\/wp\/v2\/posts\/2398","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.govisachina.com\/zh\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.govisachina.com\/zh\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.govisachina.com\/zh\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.govisachina.com\/zh\/wp-json\/wp\/v2\/comments?post=2398"}],"version-history":[{"count":1,"href":"https:\/\/www.govisachina.com\/zh\/wp-json\/wp\/v2\/posts\/2398\/revisions"}],"predecessor-version":[{"id":2399,"href":"https:\/\/www.govisachina.com\/zh\/wp-json\/wp\/v2\/posts\/2398\/revisions\/2399"}],"wp:attachment":[{"href":"https:\/\/www.govisachina.com\/zh\/wp-json\/wp\/v2\/media?parent=2398"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.govisachina.com\/zh\/wp-json\/wp\/v2\/categories?post=2398"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.govisachina.com\/zh\/wp-json\/wp\/v2\/tags?post=2398"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}